Barts Health NHS Trust requires a single, specialist chemotherapy electronic prescribing system for cancer services for use across the Trust. The solution needs to have the capability of interfacing with numerous IT systems to provide both clinical and administrative functions, with the ability to support services that are located across multiple sites, both in acute and community/outpatient settings.

The supplier will be contracted for the supply and maintenance of a Chemotherapy Electronic Prescribing and Medicines Administration Information Technology System which must include Haemato-oncology and Solid Tumours and Paediatric Oncology,

The new solution must have the capability of integrating with other software used within the Trust and external to the Trust. For example, the Trust’s current Electronic Patient Records Cerner Millennium across all Trust’s sites plus pathology results from WinPath, but not limited to 2-way electronic data transfer with Cerner Millennium and EPIC.

The service provider will be expected to implement an oncology e-prescribing system within the St Barts Hospital production environment with full compatibility and integration of services within 6-12 months of contract sign off for a period of 3 years plus one (1 + 1) year extension.

The service provider will supply electronic prescribing, medicines administration and dispensing activities, including worksheets, treatment/patient labels, dispensing and storage details — in all settings: inpatient, discharge (TTH) (including day or short leave), day case and outpatient, and all prescriber types or to be actively developing this for implementation within 6-12 months of award of contract.

The new solution must provide the following key functionality: (including but not limited too):

— provision of specialist chemotherapy e-Prescribing providing complete end-to-end chemotherapy prescribing solution including predefined regimens, prescribing, scheduling, dispensing, through to chemotherapy administration and reporting,

— the ability to integrate with other software solutions both internal and external to the Trust. In particular, with the increasing integration of cytotoxic treatment and radiotherapy integrate with radiotherapy treatment and verification systems to support chemo-radiation regimens. The integration must be capable of 2-way communication with other Trust solutions ensuring critical clinical information is shared,

— the ability to accommodate all of the Trust’s cancer patients for the duration of the contract including any possible future service expansion requirements. Automatic dose calculations, allergy and sensitivity alerting, decision support linked to pathology and toxicity, drug-to-drug interaction support, and bar-coded wristband and drug scanning,

— enable the Trust to analyse and audit all clinical processes of the Trust’s chemotherapy prescribing activities and be fully compliant with all national reporting requirements including SACT,

— the provider must provide integration capability to integrate with pre-defined Barts application currently in use, as part of in-flight projects and new projects,

— enable Trust to migrate data from previous chemotherapy IT systems